SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 232 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $75,000 | +74.4% | 47,595 | +121.2% | 0.01% | +66.7% |
| Q2 2022 | $43,000 | -94.3% | 21,521 | -93.3% | 0.01% | -94.0% |
| Q1 2022 | $748,000 | +364.6% | 321,129 | +825.4% | 0.10% | +400.0% |
| Q4 2021 | $161,000 | -40.4% | 34,701 | -1.9% | 0.02% | -28.6% |
| Q3 2021 | $270,000 | +26.8% | 35,363 | +37.0% | 0.03% | -20.0% |
| Q1 2021 | $213,000 | +69.0% | 25,808 | +40.1% | 0.04% | +66.7% |
| Q4 2020 | $126,000 | -77.5% | 18,418 | -76.4% | 0.02% | -25.0% |
| Q2 2018 | $561,000 | -53.8% | 77,895 | -66.9% | 0.03% | -56.2% |
| Q1 2018 | $1,213,000 | +1361.4% | 235,495 | +1283.7% | 0.06% | +1180.0% |
| Q4 2016 | $83,000 | -20.2% | 17,019 | +42.6% | 0.01% | 0.0% |
| Q4 2015 | $104,000 | -88.9% | 11,933 | -89.4% | 0.01% | -89.1% |
| Q3 2015 | $940,000 | +214.4% | 112,067 | +332.9% | 0.05% | +283.3% |
| Q1 2015 | $299,000 | – | 25,889 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| B. Riley Financial, Inc. | 5,216,250 | $4,621,598 | 1.04% |
| B. Riley Securities, Inc. | 5,216,250 | $4,621,598 | 1.00% |
| EMFO, LLC | 209,398 | $185,527 | 0.19% |
| Wellspring Financial Advisors, LLC | 483,551 | $428,426 | 0.14% |
| Mayo Clinic | 300,000 | $267,000 | 0.14% |
| swisspartners Ltd. | 110,000 | $97,465 | 0.12% |
| Donald L. Hagan, LLC | 169,514 | $150,189 | 0.09% |
| Oaktree Fund Advisors, LLC | 66,000 | $58,476 | 0.09% |
| EUDAIMONIA ADVISORS LLC | 138,887 | $123,054 | 0.08% |
| Asset Management Resources, LLC | 138,020 | $122,286 | 0.08% |